SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-13 |
| Reported value | $460,970,513 |
| Positions | 40 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB CO | BMY | COM | $41,838,746 | 726,115 |
| MERCK & CO INC | MRK | COM | $27,885,528 | 217,008 |
| MEDTRONIC PLC | MDT | SHS | $27,571,147 | 352,437 |
| PFIZER INC | PFE | COM | $24,181,497 | 1,004,215 |
| INCYTE CORP | INCY | COM | $19,356,560 | 170,753 |
| ELEVANCE HEALTH INC FORMERLY | ELV | COM | $17,209,098 | 44,499 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | COM | $16,875,208 | 294,918 |
| THERMO FISHER SCIENTIFIC INC | TMO | COM | $16,837,674 | 33,584 |
| CVS HEALTH CORP | CVS | COM | $16,069,613 | 155,337 |
| IQVIA HLDGS INC | IQV | COM | $15,060,340 | 77,944 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.